Advancing Therapeutic Control, Tackling Inertia & Strengthening Adherence
A structured, 6-episode online clinical education initiative designed to address real-world challenges in Type 2 Diabetes management — from delayed treatment decisions to sustaining long-term control in complex patients.
- Format: Expert-led presentations + live interactive discussions
- Duration: 6 episodes | 60 minutes each
- Audience: Healthcare professionals managing patients with Type 2 Diabetes
Explore the Program
Why this Program Matters
Improve glycemic control, strengthen treatment adherence, and prevent type 2 diabetes complications through targeted therapeutic education:
-
A 6-episodes webinar series featuring international experts (Europe, USA, India, and more)
- Each episode focuses on one major challenge in the management of type 2 diabetes
- CME-Accredited Webinar: attending each episode live awards you 1 EBAC point
What makes ACT T2D Different
Structured Journey
Each episode builds on the last, addressing key steps in the care continuum - from inertia to long-term adherence.
Real-World Relevance
Focused on clinical decision-making challenges seen in everyday practice.
Expert Dialogue
Concise expert insights followed by interactive discussion to support reflection and application.
Watch the episodes now!
Episode 1 – Early Optimal Glycemic Control: a Necessity to Prevent Diabetic Complications
Episode 1 of Act T2D emphasizes early glycemic control to prevent diabetes complications and address clinical inertia. Speakers highlight the legacy effect of hyperglycemia, realistic targets, and gliclazide evidence from key trials.
Episode 2 – Sulforynuleas in Diabetes Therapy: Current Perspectives
Episode 2 of Act T2D explores the modern role of sulfonylureas (SUs) in type 2 diabetes management amid global challenges like rising prevalence and clinical inertia. Experts discuss their efficacy, safety, and fit in resource-limited settings.
Episode 3 – Combination Therapies in Diabetes Guidelines: Insights from ADA, AACE, EASD and IDF
Episode 3 of Act T2D focuses on combination therapies to overcome therapeutic inertia and boost adherence in type 2 diabetes. Guidelines from ADA/EASD, AACE, and IDF emphasize early combos for rapid control, personalized by comorbidities and resources.
Upcoming Episode – Adherence Challenges in Multi-Morbid Patients: Beyond Traditional Care Solutions
February 5, 2026
17:30 – 18:30 (IST)
Online | Live & Interactive
This session will explore:
Key factors influencing adherence in patients with multi-comorbidities
Limitations of traditional care approaches
Innovative, multidisciplinary, and digital strategies to support long-term treatment
Patient-centered interventions for sustained clinical outcomes
The ACT-T2D Clinical Journey
A progressive learning pathway addressing real-world challenges across the diabetes care continuum.
Inertia
Delayed treatment intensification despite unmet glycaemic targets.
Control
Timely therapy decisions to help patients achieve glycaemic goals.
Sustainability
Maintaining control through appropriate therapy choices.
Adherence
Supporting long-term treatment adherence in real-world care.